Price
$21.65+9.62%Social Signal Score
Analyst Ratings
16 analysts52-week range
- Last close
- $21.65
- Off 52w high
- -47.9%
- 200-day average
- $26.84
- vs 200-day
- -19.4%
Revenue
$94.50M+7811.09%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Larry L. Wood
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 888
- Beta
- 0.90
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 3.03
Financials
Revenue
$94.50M+7811.1%Net Income
$-26.86MEBITDA
$-23.94MFree Cash Flow
$-63.24MEPS (diluted)
$-0.47Shares Outstanding (diluted)
56.51M+1903.8%Operating Expenses
$89.77MCash & Debt
$227.91MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $308.05M | $-95.57M | $-1.72 |
| 2024 | $224.50M | $-91.41M | $-1.75 |
| 2023 | $136.19M | $-105.90M | $-2.24 |
| 2022 | $75.01M | $-87.15M | $-1.96 |
| 2021 | $34.47M | $-59.85M | $-1.37 |
| 2020 | $7.72M | $-53.02M | $-1.51 |
| 2019 | $6.17M | $-41.98M | $-1.25 |
Valuation
PRCThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
0-100.00%Social Signal Score
Mentions (6)
- Newsprnewswire.com·21d ago·Negative
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit BENSALEM TOWNSHIP, Pa., Sept. 14, 2026 /PRNewswire/ -- The Law Offices of Howard G.
View source ↗ - Newsprnewswire.com·24d ago·Negative
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit LOS ANGELES, Sept. 11, 2026 /PRNewswire/ -- The Law Offices of Frank R.
View source ↗ - Newsnewsfilecorp.com·41d ago·Positive
Notice to Long-Term Shareholders of PROCEPT BioRobotics Corporation (PRCT): Grabar Law Office Investigates Claims on Your Behalf Philadelphia, Pennsylvania--(Newsfile Corp. - August 26, 2026) - Grabar Law Office is investigating claims on behalf of shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT). What is This Investigation About?
View source ↗ - Newsfool.com·48d ago·Positive
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? The purchase involved 23,900 shares at $20.85 per share, representing an investment of ~$498,000. The transaction expanded the CEO's total equity holdings by 8%.
View source ↗ - Newsprnewswire.com·49d ago·Negative
PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Bensalem, Pa., Aug. 17, 2026 /PRNewswire/ -- The Law Offices of Howard G.
View source ↗ - Newsgurufocus.com·50d ago·Neutral
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT PR N
View source ↗
Earnings
Tue, Nov 3(in 4 weeks)
Consensus estimate $-0.39 per share
Typical surprise -1.8% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$-0.47 vs $-0.46miss
- Wed, Apr 29$-0.56 vs $-0.55miss
- Wed, Feb 25$-0.53 vs $-0.32miss
- Tue, Nov 4$-0.38 vs $-0.41beat
- Wed, Aug 6$-0.35 vs $-0.41beat
- Thu, Apr 24$-0.45 vs $-0.49beat
Estimates and results for PRCT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by PRCT officers and directors.
- Bought
- $11.8m
- Sold
- $5.3m
9 trades
22 trades
- Nouri Alalehsold
- Templin Barry Lsold
- Waters Kevinsold
- Wood Larry Lbought
- Nouri Alalehsold
- Waters Kevinsold
- Templin Barry Lsold
- Nouri Alalehsold
69 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in PRCT.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.